Supply and Delivery of Covid-19 Samples

Supply and Delivery of Covid-19 Samples

Medicines Discovery Catapult are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers.

United Kingdom-Cheshire: Medical equipments, pharmaceuticals and personal care products

2020/S 249-622717

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Medicines Discovery Catapult
Postal address: Block 35, Mereside, Alderley Park
Town: Cheshire
NUTS code: UK UNITED KINGDOM
Postal code: SK10 4TG
Country: United Kingdom
Contact person: Ms Laura Hough
E-mail: laura.hough@md.catapult.org.uk
Telephone: +44 1625708394
Internet address(es):
Main address: https://md.catapult.org.uk/
Address of the buyer profile: https://md.catapult.org.uk/

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://procontract.due-north.com/Advert/Index?advertId=de2d20a0-a040-eb11-8106-005056b64545
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://procontract.due-north.com/Advert/Index?advertId=de2d20a0-a040-eb11-8106-005056b64545

I.4)Type of the contracting authority

Other type: Medical/health — research

I.5)Main activity

Other activity: Medical/health — research

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

The Supply and Delivery of Covid-19 Samples

 

Reference number: DN517078

II.1.2)Main CPV code

33000000 Medical equipments, pharmaceuticals and personal care products

II.1.3)Type of contract

Supplies

II.1.4)Short description:

 

Medicines Discovery Catapult (MDC) are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.

This Invitation to Tender (ITT) has been issued by MDC for the establishment of a framework agreement for the supply and delivery of Covid-19 Samples for delivery to Oncimmune at the following address:

FAO Natalia Hudson, Oncimmune, MediCity, D6 Thane Road, Nottingham, NG90 6BH.

This ITT is in accordance with the Public Contracts Regulations 2015. The contract notice has been advertised in the supplement to the Official Journal of the European Union and on contracts finder. The process is being conducted under the EU Procurement Directive’s open procedure.

Tenders shall remain open for acceptance by MDC for 120 days from the tender deadline date. The purchase of Covid-19 Samples shall include the cost of collection, storage and delivery as well as any administrative requirements.

The supplier shall ensure they have measures in place to ensure the fulfilment of the contract in the event of any developments from Britain’s exit from the European Union (BREXIT). The tenderer must state in their tender submission if there are any concerns with the Tenderer fulfilling its obligations under the contract due to BREXIT. The costs quoted in the pricing schedule appendix 2 are fixed for the life of the contract and must include the costs to serve associated with the administration and management of the contract including but not limited to; all costs associated with BREXIT, and all the points in this document, the MDC contract appendix 1 and the Specification appendix 3.

The tender is for the establishment of a framework agreement for the supply and delivery of Covid-19 samples. It is intended that a maximum of six (6) suppliers will be appointed to the framework agreement. These will be the tenderers who achieve the highest total scores based on the award criteria. If a number of suppliers score equally and fall into joint sixth (6th) place, then all tenderers in equal sixth (6th) place will be awarded a place on the framework agreement.

The purchase of the Covid-19 Samples is subject to the approval of MDC funders as such the Tenderer accept and acknowledge that by issuing this tender MDC shall not be bound to accept any Tender and reserves the right not to conclude a framework agreement for the supply and delivery of Covid-19 samples for which tenders are invited.

MDC have a GBP 450 000.00 budget for the collection, supply and delivery of 3 000 Covid-19 samples under this framework agreement, however there is no guaranteed level of expenditure on this framework agreement.

If it is deemed in MDC’s best interest to not use this framework agreement, MDC shall have the right to procure samples outside of this framework agreement.

This framework agreement is for a 24-month period, with an option to extend for a further 12 months, or until such time as the requisite number of samples have been collected (whether this is a shorter period).

Tender submissions, the resulting framework agreement and any call off contracts shall be based on the MDC Contract appendix 1.

 

II.1.5)Estimated total value

Value excluding VAT: 550 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description

II.2.2)Additional CPV code(s)

33000000 Medical equipments, pharmaceuticals and personal care products

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM

II.2.4)Description of the procurement:

 

Medicines Discovery Catapult (MDC) are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.

This Invitation to Tender (ITT) has been issued by MDC for the establishment of a framework agreement for the supply and delivery of Covid-19 Samples for delivery to Oncimmune at the following address:

FAO Natalia Hudson, Oncimmune, MediCity, D6 Thane Road, Nottingham, NG90 6BH.

This ITT is in accordance with the Public Contracts Regulations 2015. The contract notice has been advertised in the supplement to the Official Journal of the European Union and on Contracts Finder. The process is being conducted under the EU Procurement Directive’s open procedure.

Tenders shall remain open for acceptance by MDC for 120 days from the Tender deadline date. The purchase of Covid-19 Samples shall include the cost of collection, storage and delivery as well as any administrative requirements.

The supplier shall ensure they have measures in place to ensure the fulfilment of the contract in the event of any developments from Britain’s exit from the European Union (BREXIT). The tenderer must state in their tender submission if there are any concerns with the Tenderer fulfilling its obligations under the contract due to BREXIT. The costs quoted in the pricing schedule appendix 2 are fixed for the life of the contract and must include the costs to serve associated with the administration and management of the contract including but not limited to; all costs associated with BREXIT, and all the points in this document, the MDC contract appendix 1 and the specification appendix 3.

The tender is for the establishment of a framework agreement for the supply and delivery of Covid-19 Samples. It is intended that a maximum of six (6) suppliers will be appointed to the framework agreement. These will be the tenderers who achieve the highest total scores based on the award criteria. If a number of suppliers score equally and fall into joint sixth (6th) place, then all Tenderers in equal sixth (6th) place will be awarded a place on the framework agreement.

The purchase of the Covid-19 samples is subject to the approval of MDC funders as such the Tenderer accept and acknowledge that by issuing this tender MDC shall not be bound to accept any Tender and reserves the right not to conclude a framework agreement for the supply and delivery of Covid-19 samples for which tenders are invited.

MDC have a GBP 450 000.00 budget for the collection, supply and delivery of 3000 Covid-19 samples under this framework agreement, however there is no guaranteed level of expenditure on this framework agreement.

If it is deemed in MDC’s best interest to not use this framework agreement, MDC shall have the right to procure samples outside of this framework agreement.

This framework agreement is for a 24-month period, with an option to extend for a further 12 months, or until such time as the requisite number of samples have been collected (whether this is a shorter period).

Tender submissions, the resulting framework agreement and any call off contracts shall be based on the MDC Contract appendix 1.

 

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 550 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure

IV.1.3)Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement
Framework agreement with several operators
Envisaged maximum number of participants to the framework agreement: 6
In the case of framework agreements, provide justification for any duration exceeding 4 years:

 

 

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 22/01/2021
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)

IV.2.7)Conditions for opening of tenders

Date: 22/01/2021
Local time: 12:00
Place:

Medicines Discovery Catapult, Block 35, Mereside, Alderley Park, Cheshire, SK10 4TG.

 

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.3)Additional information:
VI.4)Procedures for review

VI.4.1)Review body

Official name: Medicines Discovery Catapult
Postal address: Block 35 Mereside Alderley Park
Town: Cheshire
Postal code: SK10 4TG
Country: United Kingdom

VI.5)Date of dispatch of this notice:

17/12/2020